Patients in the CKD progression group had a higher prevalence of hypertension (P < 0.001), lower serum albumin levels and eGFR (P < 0.001 and P < 0.001, respectively), and higher urinary PCR levels (P < 0.001). This evidence concerns the gene ALB and Hypertension.